Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer
Titel:
Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer
Auteur:
Mross, Klaus Frost, Annette Scheulen, Max E Krauss, Jürgen Strumberg, Dirk Schultheiss, Beate Fasol, Ulrike Büchert, Martin Krätzschmer, Jörn Delesen, Heinz Rajagopalan, Prabhu Christensen, Olaf